|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0021344,
umls-concept:C0035647,
umls-concept:C0042210,
umls-concept:C0205195,
umls-concept:C0334276,
umls-concept:C0349459,
umls-concept:C0355642,
umls-concept:C0445202,
umls-concept:C0450094,
umls-concept:C0677582,
umls-concept:C0687697,
umls-concept:C0936012,
umls-concept:C1280500,
umls-concept:C1519275,
umls-concept:C1883548,
umls-concept:C2919019
|
|
pubmed:issue |
9576
|
|
pubmed:dateCreated |
2007-6-4
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS), are caused by oncogenic human papillomavirus (HPV). In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
2
|
|
pubmed:volume |
369
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1861-8
|
|
pubmed:dateRevised |
2007-12-20
|
|
pubmed:meshHeading |
pubmed-meshheading:17544766-Adenocarcinoma,
pubmed-meshheading:17544766-Adolescent,
pubmed-meshheading:17544766-Adult,
pubmed-meshheading:17544766-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:17544766-Double-Blind Method,
pubmed-meshheading:17544766-Endpoint Determination,
pubmed-meshheading:17544766-Female,
pubmed-meshheading:17544766-Follow-Up Studies,
pubmed-meshheading:17544766-Human papillomavirus 16,
pubmed-meshheading:17544766-Human papillomavirus 18,
pubmed-meshheading:17544766-Humans,
pubmed-meshheading:17544766-Multicenter Studies as Topic,
pubmed-meshheading:17544766-Papillomavirus Vaccines,
pubmed-meshheading:17544766-Randomized Controlled Trials as Topic
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Jesse Hill Jr Drive, SE, Atlanta, GA 30303, USA. kevin.ault@emory.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
